COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,689 Articles (22,913 medRxiv, 8,776 bioRxiv)

Most recent first Previous |  Page 1938: Articles 19371-19380  | Next

School and community reopening during the COVID-19 pandemic: a mathematical modeling study
Yuan, P., Aruffo, E., ogden, N., Tan, Y., Gatov, E., Gournis, E., Collier, S., Li, Q., Moyles, I., Bouchra, N., Zhu, H.
10.1101/2021.01.13.21249753 — Posted: 2021-01-15
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients.
Crescenzo-Chaigne, B., Behillil, S., Enouf, V., Escriou, N., Petres, S., Ungeheuer, M. N., Ghosn, J., Tubiana, S., Bouadma, L., van der Werf, S., Demeret, C., French COVID cohort study group
10.1101/2021.01.13.20249038 — Posted: 2021-01-15
Mass Testing with Contact Tracing Compared to Test and Trace for Effective Suppression of COVID-19 in the UK: A rapid review
Mbwogge, M.
10.1101/2021.01.13.21249749 — Posted: 2021-01-15
A Novel Multiplex PCR Based Detection Assay Using Saliva or Nasopharyngeal Samples for SARS-Cov-2, Influenza A and B: Clinical Validation and Utility for Mass Surveillance.
Sahajpal, N. S., Mondal, A. K., Ananth, S., Njau, A., Ahluwalia, P., Oza, E., Ross, T., Kota, V., Kothandaraman, A., Fulzele, S., Hegde, M., Chaubey, A., Rojiani, A. M., Kolhe, R.
10.1101/2021.01.13.21249629 — Posted: 2021-01-15
Real-time optical analysis of a colorimetric LAMP assay for SARS-CoV-2 in saliva with a handheld instrument improves accuracy compared to endpoint assessment
Diaz, L., Johnson, B. E., Jenkins, D. M.
10.1101/2021.01.13.21249412 — Posted: 2021-01-15
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
Camerini, D., Randall, A. Z., Trappl-Kimmons, K., Oberai, A., Hung, C., Edgar, J., Shandling, A., Huynh, V., Teng, A. A., Hermanson, G., Pablo, J. V., Stumpf, M. M., Lester, S. N., Harcourt, J., Tamin, A., Rasheed, M., Thornburg, N. J., Satheshkumar, P. S., Liang, X., Kennedy, R. B., Yee, A., Townsend, M., Campo, J. J.
10.1101/2021.01.14.21249690 — Posted: 2021-01-15 Discussion: Onsite
The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centres
Stephenson, E., Reynolds, G., Botting, R. A., Calero-Nieto, F. J., Morgan, M., Tuong, Z. K., Bach, K., Sungnak, W., Worlock, K. B., Yoshida, M., Kumasaka, N., Kania, K., Engelbert, J., Olabi, B., Spegarova, J. S., Wilson, N. K., Mende, N., Jardine, L., Gardner, L. C., Goh, I., Horsfall, D., McGrath, J., Webb, S., Mather, M. W., Lindeboom, R. G., Dann, E., Huang, N., Polanski, K., Prigmore, E., Gothe, F., Scott, J., Payne, R. P., Baker, K. F., Hanrath, A. T., Schim van der Loeff, I. C., Barr, A. S., Sanchez-Gonzalez, A., Bergamaschi, L., Mescia, F., Barnes, J. L., Kilich, E., de Wilton, A., Saigal, A., Saleh, A., Janes, S. M., Smith, C. M., Gopee, N., Wilson, C., Coupland, P., Coxhead, J. M., Kiselev, V. Y., van Dongen, S., Bacardit, J., King, H. W., Rostron, A. J., Simpson, A. J., Hambleton, S., Laurenti, E., Lyons, P. A., Meyer, K. B., Nikolic, M. Z., Duncan, C. J., Smith, K., Teichmann, S. A., Clatworthy, M. R., Marioni, J. C., Gottgens, B., Haniffa, M.
10.1101/2021.01.13.21249725 — Posted: 2021-01-15
Understanding COVID-19 dynamics and the effects of interventions in the Philippines: A mathematical modelling study
Caldwell, J. M., de Lara-Tuprio, E., Teng, T. R. Y., Estuar, M. R. J. E., Sarmiento, R. F., Abayawardana, M., Leong, R. N. F., Gray, R. T., Wood, J. G., McBryde, E., Ragonnet, R., Trauer, J. M.
10.1101/2021.01.14.21249848 — Posted: 2021-01-15
COVID-19: Rapid Antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testing
UK COVID-19 Lateral Flow Oversight Team, , Peto, T.
10.1101/2021.01.13.21249563 — Posted: 2021-01-15
SARS-Cov-2 prevalence, transmission, health-related outcomes and control strategies in homeless shelters: systematic review and meta-analysis
Mohsenpour, A. M., Bozorgmehr, K., Rohleder, S., Stratil, J., Costa, D.
10.1101/2021.01.14.21249851 — Posted: 2021-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).